← Solid-Tumor Biomarkers
Solid-tumor biomarker
Alpha-fetoprotein (AFP)
A laboratory biomarker associated with assessment and monitoring in selected solid-tumor settings.
Product overview
What it is.
- A blood test that measures alpha-fetoprotein, a protein made by the liver.
- Helps diagnose and monitor cancers of the liver, ovaries, or testicles that produce high AFP levels, when used with other exams and tests.
- Used to follow how a cancer responds to treatment and to check whether it has returned.
- Cannot screen for or diagnose cancer on its own: other conditions raise AFP, and some cancers leave it normal.
Portfolio information
From the original portfolio.
Content review draft
The former site discusses AFP in relation to liver, ovarian, and testicular cancers, and notes that results are interpreted alongside other clinical information.
This page preserves the former site’s product information for review. It does not establish current Canadian availability, approved indications, performance, or prescribing information. Request verified documentation before relying on it.
Request verified informationExplore this area